| Schedule of Operating Results |
The Company's operations are just organized into one business segment
based on the nature of products and services offered. Summary operating results for each of its products were as follows:
| | |
Three months Ended
March 31, | | |
Nine months Ended
March 31, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Sales | |
| | |
| | |
| |
| Anti-Aging & Immune Support | |
$ | 14,010 | | |
$ | 50,008 | | |
$ | 184,764 | | |
$ | 254,404 | |
| Targeted System Support | |
| 9,655 | | |
| 6,140 | | |
| 55,286 | | |
| 32,809 | |
| Herbal Insulin Support | |
| 2,478 | | |
| - | | |
| 18,752 | | |
| - | |
| Total sales | |
$ | 26,143 | | |
$ | 56,148 | | |
$ | 258,802 | | |
$ | 287,213 | |
| Cost of Goods Sold | |
| | | |
| | | |
| | | |
| | |
| Anti-Aging & Immune Support | |
$ | 1,226 | | |
$ | 5,858 | | |
$ | 64,286 | | |
$ | 22,505 | |
| Targeted System Support | |
| 1,392 | | |
| 473 | | |
| 16,118 | | |
| 3,003 | |
| Herbal Insulin Support | |
| 992 | | |
| - | | |
| 6,650 | | |
| - | |
| Total cost of goods sold | |
$ | 3,610 | | |
$ | 6,331 | | |
$ | 87,054 | | |
$ | 25,508 | |
| Gross Profit | |
| | | |
| | | |
| | | |
| | |
| Anti-Aging & Immune Support | |
$ | 12,784 | | |
$ | 44,150 | | |
$ | 120,478 | | |
$ | 231,899 | |
| Targeted System Support | |
| 8,263 | | |
| 5,667 | | |
| 39,168 | | |
| 29,806 | |
| Herbal Insulin Support | |
| 1,486 | | |
| - | | |
| 12,102 | | |
| - | |
| Total gross profit | |
$ | 22,533 | | |
$ | 49,817 | | |
$ | 171,748 | | |
$ | 261,705 | |
| Selling Expense | |
| | | |
| | | |
| | | |
| | |
| Anti-Aging & Immune Support | |
$ | 628 | | |
$ | 13,363 | | |
$ | 17,600 | | |
$ | 33,855 | |
| Targeted System Support | |
| 3,068 | | |
| 892 | | |
| 15,206 | | |
| 3,594 | |
| Herbal Insulin Support | |
| 2,190 | | |
| - | | |
| 25,406 | | |
| - | |
| Total selling expense | |
$ | 5,886 | | |
$ | 14,255 | | |
$ | 58,212 | | |
$ | 37,449 | |
|
| Schedule of Concentration in Account Payable |
| | |
For the three months ended March 31, | | |
For the nine months ended March 31, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
Amounts | | |
Percentages | | |
Amounts | | |
Percentages | | |
Amounts | | |
Percentages | | |
Amounts | | |
Percentages | |
| Customer A | |
$ | 3,406 | | |
| 13 | % | |
$ | 10,560 | | |
| 19 | % | |
$ | 57,000 | | |
| 22 | % | |
$ | 32,980 | | |
| 11 | % |
| Customer B | |
| 2,613 | | |
| 10 | % | |
| 6,900 | | |
| 12 | % | |
| 55,877 | | |
| 22 | % | |
| - | | |
| - | % |
| Customer C | |
| 2,600 | | |
| 10 | % | |
| 6,708 | | |
| 12 | % | |
| - | | |
| - | % | |
| - | | |
| - | % |
| Customer D | |
| - | | |
| - | % | |
| 6,012 | | |
| 11 | % | |
| - | | |
| - | % | |
| - | | |
| - | % |
| Customer E | |
| - | | |
| - | % | |
| 6,000 | | |
| 11 | % | |
| - | | |
| - | % | |
| - | | |
| - | % |
| Customer F | |
$ | - | | |
| - | % | |
$ | 5,580 | | |
| 10 | % | |
$ | - | | |
| - | % | |
$ | - | | |
| - | % |
| | |
For the three months ended March 31, | | |
For the nine months ended March 31, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
Amounts | | |
Percentages | | |
Amounts | | |
Percentages | | |
Amounts | | |
Percentages | | |
Amounts | | |
Percentages | |
| Supplier A | |
$ | 5,211 | | |
| 100 | % | |
$ | 5,138 | | |
| 100 | % | |
$ | 38,920 | | |
| 53 | % | |
$ | 41,668 | | |
| 63 | % |
| Supplier B | |
| - | | |
| - | | |
| - | | |
| - | | |
| 31,668 | | |
| 43 | % | |
| 17,019 | | |
| 25 | % |
| Supplier C | |
$ | - | | |
| - | % | |
$ | - | | |
| - | % | |
$ | - | | |
| - | % | |
$ | 7,940 | | |
| 12 | % |
|